PHARMACOR RASAGILINE is indicated for the symptomatic treatment of idiopathic Parkinson's disease (PD) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.
Tablet Description
White to off white, uncoated round, flat, bevelled tablets debossed with "RAS" on one side and "1" on other side
PHARMACOR RASAGILINE is indicated for the symptomatic treatment of idiopathic Parkinson's disease (PD) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.
Tablet Description
White to off white, uncoated round, flat, bevelled tablets debossed with "RAS" on one side and "1" on other side
PHARMACOR RASAGILINE is indicated for the symptomatic treatment of idiopathic Parkinson's disease (PD) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.
Tablet Description
White to off white, uncoated round, flat, bevelled tablets debossed with "RAS" on one side and "1" on other side
PHARMACOR RASAGILINE is indicated for the symptomatic treatment of idiopathic Parkinson's disease (PD) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.
Tablet Description
White to off white, uncoated round, flat, bevelled tablets debossed with "RAS" on one side and "1" on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Generic Name: Rasagiline
PBS Listed: ✘
RPBS: ✘
Strength: 1mg
Dosage: Tabs
Pack Size: 30
Schedule: S4
Shelf Life: 24 Month
Innovator: Azilect®
Warnings
Connecting Care, Simplifying Supply.
At Pharmacor, we bridge the gap between healthcare providers and seamless supply solutions, ensuring care is always within reach.